Sony Salzman is a freelance journalist reporting on health care and medicine, who has won awards in both narrative writing and radio journalism. Follow Salzman on Twitter: @sonysalz.
Latest by Sony Salzman
Will potential study participants choose a vaccine trial over getting access to PrEP?
Next week, 6,000 HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.
"The biggest barrier to care for transgender people is a lack of knowledgeable providers," said lead author Joshua D. Safer, M.D., with Mount Sinai Medical System.
Could home-based self-swabs and mobile technology be helpful tools in the future of HIV prevention?
No meaningful difference was found in either injectable or implant birth control when compared to an IUD.
Starting July 1, some HIV meds that are widely used will be excluded from their list.
"I would like to dispel the notion that scientists in general are old white men in lab coats," said HIV researcher Zandrea Ambrose, Ph.D, a participant in the "500 Women Scientists" movement.
Rectal and throat tests matter too, and providers should be recommending them.
When people living with HIV are admitted to a hospital, they may not be able to bring their medications with them, and could be prescribed new medication by a doctor who doesn't understand their complete medical history.
However, a number of leading clinicians argue that the results should not deter care providers from prescribing PrEP for patients who are most at risk for HIV.